체외 단백질 발현 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global In Vitro Protein Expression Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• In Vitro Protein Expression Market Size (2024E): US$239.5 Mn
• Projected Market Value (2031F): US$385.9 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 7.1%

In Vitro Protein Expression Market - Report Scope:

The global in vitro protein expression market encompasses a wide range of expression systems, including cell-free protein expression, prokaryotic expression systems, and eukaryotic expression systems. Market growth is primarily fueled by the increasing demand for recombinant protein production, advancements in synthetic biology, and the rising adoption of cell-free protein synthesis technologies. The market's expansion is further supported by growing research activities in proteomics and the pharmaceutical sector.

Market Growth Drivers:

Several factors are driving the growth of the global in vitro protein expression market. These include the escalating demand for protein-based therapeutics, the need for rapid protein synthesis in drug discovery processes, and the increasing focus on personalized medicine. Advancements in molecular biology techniques and the availability of robust expression systems are facilitating this growth. Additionally, government funding for biotechnological research and partnerships between academic institutions and biopharma companies contribute to market expansion.

Market Restraints:

Despite the promising growth prospects, the in vitro protein expression market faces certain challenges. High costs associated with protein expression systems and reagents act as significant barriers, particularly for small and medium-sized enterprises. Technical complexities and the need for skilled personnel further restrict market penetration. Moreover, the regulatory challenges related to the use of recombinant proteins in therapeutics may limit the market's growth potential.

Market Opportunities:

The in vitro protein expression market presents significant growth opportunities driven by the rising adoption of cell-free protein synthesis for high-throughput screening applications. The development of cost-effective and efficient expression systems is expected to attract more players to the market. Additionally, the growing emphasis on synthetic biology and advancements in gene-editing technologies like CRISPR-Cas9 open new avenues for innovation. Expanding applications of protein expression in areas such as antibody development, vaccine production, and biosensor design further enhance market opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the in vitro protein expression market?
• Which expression systems are gaining the highest adoption across different regions?
• How are technological innovations influencing the competitive landscape of the in vitro protein expression market?
• Who are the key players in the in vitro protein expression market, and what strategies are they employing to maintain their market positions?
• What are the emerging trends and future outlooks for the global in vitro protein expression market?

Competitive Intelligence and Business Strategy:

Leading companies in the global in vitro protein expression market, such as Thermo Fisher Scientific Inc., Merck KGaA, and Promega Corporation, are focusing on product innovation and expanding their portfolios of expression systems. These companies are heavily investing in the development of advanced technologies for protein synthesis and establishing strategic partnerships with research institutes. Emphasis on sustainability and the introduction of eco-friendly reagents are emerging trends in the competitive landscape.

Key Companies Profiled:

• Thermo Fisher Scientific, Inc.
• Takara Bio Company
• New England Biolabs
• Promega Corporation
• Jena Bioscience GmbH
• GeneCopoeia, Inc.
• Biotechrabbit GmbH
• Cube Biotech GmbH
• CellFree Sciences Co., Ltd.
• Bioneer Corporation
• Others.

In Vitro Protein Expression Industry Research by Category:

By Product Type

• coli System
• Rabbit Reticulocytes System
• Wheat Germ System
• Insect Cells System
• Mammalian System

By Expression Mode

• Continuous Flow Expression
• Batch Expression

By End User

• Biotechnological Companies
• Pharmaceutical Companies
• Contract Research Organizations
• Academic and Research Institutes

By Application

• Enzyme Engineering
• Protein Labeling
• Protein-Protein Interaction
• Protein Purification

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• MEA

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Taxonomy
• 2.2. Market Definition
• 2.3. Product Comparison

3. Market View Point

• 3.1. Macro-Economic Factors
• 3.2. Drivers
  • 3.2.1. Supply Side Drivers
  • 3.2.2. Demand Side Drivers
• 3.3. Restraints
• 3.4. Opportunity Analysis
• 3.5. Trends
• 3.6. Pricing Analysis by Region
• 3.7. Primary Insights and Verbatim

4. North America In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 4.1. Introduction
• 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 4.2.1. U.S.
  • 4.2.2. Canada
• 4.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 4.3.1. U.S.
  • 4.3.2. Canada
• 4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 4.4.1. E-coli In-Vitro Protein Expression System
  • 4.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 4.4.3. Wheat Germ In-Vitro Protein Expression System
  • 4.4.4. Insect Cells In-Vitro Protein Expression System
  • 4.4.5. Mammalian In-Vitro Protein Expression System
• 4.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 4.5.1. E-coli In-Vitro Protein Expression System
  • 4.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 4.5.3. Wheat Germ In-Vitro Protein Expression System
  • 4.5.4. Insect Cells In-Vitro Protein Expression System
  • 4.5.5. Mammalian In-Vitro Protein Expression System
• 4.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 4.6.1. Enzyme Engineering
  • 4.6.2. Protein Labeling
  • 4.6.3. Protein-Protein interaction
  • 4.6.4. Protein Purification
• 4.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 4.7.1. Enzyme Engineering
  • 4.7.2. Protein Labeling
  • 4.7.3. Protein-Protein interaction
  • 4.7.4. Protein Purification
• 4.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 4.8.1. Continuous Flow Expression System
  • 4.8.2. Batch Expression System
• 4.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 4.9.1. Continuous Flow Expression System
  • 4.9.2. Batch Expression System
• 4.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 4.10.1. Biotechnological Companies
  • 4.10.2. Pharmaceutical Companies
  • 4.10.3. Contract Research Organizations
  • 4.10.4. Academic and Research Institutes
• 4.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 4.11.1. Biotechnological Companies
  • 4.11.2. Pharmaceutical Companies
  • 4.11.3. Contract Research Organizations
  • 4.11.4. Academic and Research Institutes
• 4.12. Market Attractiveness Analysis
  • 4.12.1. By Country
  • 4.12.2. By Product Type
  • 4.12.3. By Application
  • 4.12.4. By Expression System
  • 4.12.5. By End User
• 4.13. Drivers and Restraints: Impact Analysis
• 4.14. Key Participants Market Presence (Intensity Map)

5. Latin America In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 5.1. Introduction
• 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 5.2.1. Brazil
  • 5.2.2. Mexico
  • 5.2.3. Argentina
  • 5.2.4. Rest of Latin America
• 5.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 5.3.1. Brazil
  • 5.3.2. Mexico
  • 5.3.3. Argentina
  • 5.3.4. Rest of Latin America
• 5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 5.4.1. E-coli In-Vitro Protein Expression System
  • 5.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 5.4.3. Wheat Germ In-Vitro Protein Expression System
  • 5.4.4. Insect Cells In-Vitro Protein Expression System
  • 5.4.5. Mammalian In-Vitro Protein Expression System
• 5.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 5.5.1. E-coli In-Vitro Protein Expression System
  • 5.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 5.5.3. Wheat Germ In-Vitro Protein Expression System
  • 5.5.4. Insect Cells In-Vitro Protein Expression System
  • 5.5.5. Mammalian In-Vitro Protein Expression System
• 5.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 5.6.1. Enzyme Engineering
  • 5.6.2. Protein Labeling
  • 5.6.3. Protein-Protein interaction
  • 5.6.4. Protein Purification
• 5.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 5.7.1. Enzyme Engineering
  • 5.7.2. Protein Labeling
  • 5.7.3. Protein-Protein interaction
  • 5.7.4. Protein Purification
• 5.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 5.8.1. Continuous Flow Expression System
  • 5.8.2. Batch Expression System
• 5.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 5.9.1. Continuous Flow Expression System
  • 5.9.2. Batch Expression System
• 5.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 5.10.1. Biotechnological Companies
  • 5.10.2. Pharmaceutical Companies
  • 5.10.3. Contract Research Organizations
  • 5.10.4. Academic and Research Institutes
• 5.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 5.11.1. Biotechnological Companies
  • 5.11.2. Pharmaceutical Companies
  • 5.11.3. Contract Research Organizations
  • 5.11.4. Academic and Research Institutes
• 5.12. Market Attractiveness Analysis
  • 5.12.1. By Country
  • 5.12.2. By Product Type
  • 5.12.3. By Application
  • 5.12.4. By Expression System
  • 5.12.5. By End User
• 5.13. Drivers and Restraints: Impact Analysis
• 5.14. Key Participants Market Presence (Intensity Map)

6. Europe In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 6.1. Introduction
• 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 6.2.1. U.K
  • 6.2.2. Germany
  • 6.2.3. France
  • 6.2.4. Spain
  • 6.2.5. Italy
  • 6.2.6. Poland
  • 6.2.7. Russia
  • 6.2.8. Rest of Europe
• 6.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 6.3.1. U.K
  • 6.3.2. Germany
  • 6.3.3. France
  • 6.3.4. Spain
  • 6.3.5. Italy
  • 6.3.6. Poland
  • 6.3.7. Russia
  • 6.3.8. Rest of Europe
• 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 6.4.1. E-coli In-Vitro Protein Expression System
  • 6.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 6.4.3. Wheat Germ In-Vitro Protein Expression System
  • 6.4.4. Insect Cells In-Vitro Protein Expression System
  • 6.4.5. Mammalian In-Vitro Protein Expression System
• 6.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 6.5.1. E-coli In-Vitro Protein Expression System
  • 6.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 6.5.3. Wheat Germ In-Vitro Protein Expression System
  • 6.5.4. Insect Cells In-Vitro Protein Expression System
  • 6.5.5. Mammalian In-Vitro Protein Expression System
• 6.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 6.6.1. Enzyme Engineering
  • 6.6.2. Protein Labeling
  • 6.6.3. Protein-Protein interaction
  • 6.6.4. Protein Purification
• 6.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 6.7.1. Enzyme Engineering
  • 6.7.2. Protein Labeling
  • 6.7.3. Protein-Protein interaction
  • 6.7.4. Protein Purification
• 6.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 6.8.1. Continuous Flow Expression System
  • 6.8.2. Batch Expression System
• 6.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 6.9.1. Continuous Flow Expression System
  • 6.9.2. Batch Expression System
• 6.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 6.10.1. Biotechnological Companies
  • 6.10.2. Pharmaceutical Companies
  • 6.10.3. Contract Research Organizations
  • 6.10.4. Academic and Research Institutes
• 6.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 6.11.1. Biotechnological Companies
  • 6.11.2. Pharmaceutical Companies
  • 6.11.3. Contract Research Organizations
  • 6.11.4. Academic and Research Institutes
• 6.12. Market Attractiveness Analysis
  • 6.12.1. By Country
  • 6.12.2. By Product Type
  • 6.12.3. By Application
  • 6.12.4. By Expression System
  • 6.12.5. By End User
• 6.13. Drivers and Restraints: Impact Analysis
• 6.14. Key Participants Market Presence (Intensity Map)

7. Asia Pacific In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 7.1. Introduction
• 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 7.2.1. China
  • 7.2.2. Japan
  • 7.2.3. Australia
  • 7.2.4. India
  • 7.2.5. Rest of Asia-Pacific
• 7.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 7.3.1. China
  • 7.3.2. Japan
  • 7.3.3. Australia
  • 7.3.4. India
  • 7.3.5. Rest of Asia Pacific
• 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 7.4.1. E-coli In-Vitro Protein Expression System
  • 7.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 7.4.3. Wheat Germ In-Vitro Protein Expression System
  • 7.4.4. Insect Cells In-Vitro Protein Expression System
  • 7.4.5. Mammalian In-Vitro Protein Expression System
• 7.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 7.5.1. E-coli In-Vitro Protein Expression System
  • 7.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 7.5.3. Wheat Germ In-Vitro Protein Expression System
  • 7.5.4. Insect Cells In-Vitro Protein Expression System
  • 7.5.5. Mammalian In-Vitro Protein Expression System
• 7.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 7.6.1. Enzyme Engineering
  • 7.6.2. Protein Labeling
  • 7.6.3. Protein-Protein interaction
  • 7.6.4. Protein Purification
• 7.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 7.7.1. Enzyme Engineering
  • 7.7.2. Protein Labeling
  • 7.7.3. Protein-Protein interaction
  • 7.7.4. Protein Purification
• 7.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 7.8.1. Continuous Flow Expression System
  • 7.8.2. Batch Expression System
• 7.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 7.9.1. Continuous Flow Expression System
  • 7.9.2. Batch Expression System
• 7.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 7.10.1. Biotechnological Companies
  • 7.10.2. Pharmaceutical Companies
  • 7.10.3. Contract Research Organizations
  • 7.10.4. Academic and Research Institutes
• 7.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 7.11.1. Biotechnological Companies
  • 7.11.2. Pharmaceutical Companies
  • 7.11.3. Contract Research Organizations
  • 7.11.4. Academic and Research Institutes
• 7.12. Market Attractiveness Analysis
  • 7.12.1. By Country
  • 7.12.2. By Product Type
  • 7.12.3. By Application
  • 7.12.4. By Expression System
  • 7.12.5. By End User
• 7.13. Drivers and Restraints: Impact Analysis
• 7.14. Key Participants Market Presence (Intensity Map)

8. MEA In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 8.2.1. GCC Countries
  • 8.2.2. South Africa
  • 8.2.3. Rest of MEA
• 8.3. Market Size (US$ Mn) Forecast By Country, , 2024 - 2031
  • 8.3.1. GCC Countries
  • 8.3.2. South Africa
  • 8.3.3. Rest of MEA
• 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 8.4.1. E-coli In-Vitro Protein Expression System
  • 8.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 8.4.3. Wheat Germ In-Vitro Protein Expression System
  • 8.4.4. Insect Cells In-Vitro Protein Expression System
  • 8.4.5. Mammalian In-Vitro Protein Expression System
• 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 8.5.1. E-coli In-Vitro Protein Expression System
  • 8.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 8.5.3. Wheat Germ In-Vitro Protein Expression System
  • 8.5.4. Insect Cells In-Vitro Protein Expression System
  • 8.5.5. Mammalian In-Vitro Protein Expression System
• 8.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 8.6.1. Enzyme Engineering
  • 8.6.2. Protein Labeling
  • 8.6.3. Protein-Protein interaction
  • 8.6.4. Protein Purification
  • 8.6.5. Targeted Sequencing
• 8.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 8.7.1. Enzyme Engineering
  • 8.7.2. Protein Labeling
  • 8.7.3. Protein-Protein interaction
  • 8.7.4. Protein Purification
• 8.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 8.8.1. Continuous Flow Expression System
  • 8.8.2. Batch Expression System
• 8.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 8.9.1. Continuous Flow Expression System
  • 8.9.2. Batch Expression System
• 8.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 8.10.1. Biotechnological Companies
  • 8.10.2. Pharmaceutical Companies
  • 8.10.3. Contract Research Organizations
  • 8.10.4. Academic and Research Institutes
• 8.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 8.11.1. Biotechnological Companies
  • 8.11.2. Pharmaceutical Companies
  • 8.11.3. Contract Research Organizations
  • 8.11.4. Academic and Research Institutes
• 8.12. Market Attractiveness Analysis
  • 8.12.1. By Country
  • 8.12.2. By Product Type
  • 8.12.3. By Application
  • 8.12.4. By Expression System
  • 8.12.5. By End User
• 8.13. Drivers and Restraints: Impact Analysis
• 8.14. Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Competition Landscape

• 10.1. Market Structure
• 10.2. Company Share Analysis (2024)
• 10.3. Competition Dashboard
• 10.4. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments and SWOT Analysis)
  • 10.4.1. Thermo Fisher Scientific, Inc.
  • 10.4.2. Takara Bio Company
  • 10.4.3. New England Biolabs
  • 10.4.4. Promega Corporation
  • 10.4.5. Jena Bioscience GmbH
  • 10.4.6. GeneCopoeia, Inc.
  • 10.4.7. Biotechrabbit GmbH
  • 10.4.8. Cube Biotech GmbH
  • 10.4.9. CellFree Sciences Co., Ltd.
  • 10.4.10. Bioneer Corporation

11. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

• 11.1. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2023
  • 11.1.1. North America
  • 11.1.2. Latin America
  • 11.1.3. Europe
  • 11.1.4. Asia Pacific
  • 11.1.5. Middle East and Africa
• 11.2. Market Size (US$ Mn) Forecast By Region, 2024 - 2031
  • 11.2.1. North America
  • 11.2.2. Latin America
  • 11.2.3. Europe
  • 11.2.4. Asia Pacific
  • 11.2.5. Middle East and Africa
• 11.3. Market Attractiveness Analysis By Region

12. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 12.2.1. E-coli In-Vitro Protein Expression System
  • 12.2.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 12.2.3. Wheat Germ In-Vitro Protein Expression System
  • 12.2.4. Insect Cells In-Vitro Protein Expression System
  • 12.2.5. Mammalian In-Vitro Protein Expression System
• 12.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 12.3.1. E-coli In-Vitro Protein Expression System
  • 12.3.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 12.3.3. Wheat Germ In-Vitro Protein Expression System
  • 12.3.4. Insect Cells In-Vitro Protein Expression System
  • 12.3.5. Mammalian In-Vitro Protein Expression System
• 12.4. Market Attractiveness Analysis By Product Type

13. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 13.2.1. Enzyme Engineering
  • 13.2.2. Protein Labeling
  • 13.2.3. Protein-Protein interaction
  • 13.2.4. Protein Purification
• 13.3. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 13.3.1. Enzyme Engineering
  • 13.3.2. Protein Labeling
  • 13.3.3. Protein-Protein interaction
  • 13.3.4. Protein Purification
• 13.4. Market Attractiveness Analysis By Application

14. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Expression System

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 14.2.1. Continuous Flow Expression System
  • 14.2.2. Batch Expression System
• 14.3. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 14.3.1. Continuous Flow Expression System
  • 14.3.2. Batch Expression System
• 14.4. Market Attractiveness Analysis By Expression System

15. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 15.2.1. Biotechnological Companies
  • 15.2.2. Pharmaceutical Companies
  • 15.2.3. Contract Research Organizations
  • 15.2.4. Academic and Research Institutes
• 15.3. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 15.3.1. Biotechnological Companies
  • 15.3.2. Pharmaceutical Companies
  • 15.3.3. Contract Research Organizations
  • 15.3.4. Academic and Research Institutes
• 15.4. Market Attractiveness Analysis By End User

16. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 16.1. Market Size Analysis and Y-o-Y Growth
• 16.2. Absolute $ Opportunity
• 16.3. Market Volume and Y-o-Y Growth
• 16.4. Value Chain

17. Research Methodology